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A challenge in using bioactive melt-derived glass in bone regeneration is to produce scaffolds with inter-
connected pores while maintaining the amorphous nature of the glass and its associated bioactivity. Here
we introduce a method for creating porous melt-derived bioactive glass foam scaffolds with low silica
content and report in vitro and preliminary in vivo data. The gel-cast foaming process was adapted,
employing temperature controlled gelation of gelatin, rather than the in situ acrylic polymerisation used
previously. To form a 3D construct from melt derived glasses, particles must be fused via thermal pro-
cessing, termed sintering. The original Bioglass 45S5 composition crystallises upon sintering, altering
its bioactivity, due to the temperature difference between the glass transition temperature and the crys-
tallisation onset being small. Here, we optimised and compared scaffolds from three glass compositions,
ICIE16, PSrBG and 13–93, which were selected due to their widened sintering windows. Amorphous scaf-
folds with modal pore interconnect diameters between 100–150 mm and porosities of 75% had compres-
sive strengths of 3.4 ± 0.3 MPa, 8.4 ± 0.8 MPa and 15.3 ± 1.8 MPa, for ICIE16, PSrBG and 13–93
respectively. These porosities and compressive strength values are within the range of cancellous bone,
and greater than previously reported foamed scaffolds. Dental pulp stem cells attached to the scaffold
surfaces during in vitro culture and were viable. In vivo, the scaffolds were found to regenerate bone in
a rabbit model according to X-ray micro tomography imaging.
Statement of Significance
This manuscript describes a new method for making scaffolds from bioactive glasses using highly bioac-
tive glass compositions. The glass compositions have lower silica content that those that have been pre-
viously made into amorphous scaffolds and they have been designed to have similar network
connectivity to that of the original (and commercially used) 45S5 Bioglass. The aim was to match
Bioglass’ bioactivity.
The scaffolds retain the amorphous nature of bioactive glass while having an open pore structure and
compressive strength similar to porous bone (the original 45S5 Bioglass crystallises during sintering,
which can cause reduced bioactivity or instability).
The new scaffolds showed unexpectedly rapid bone regeneration in a rabbit model.
 2017 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CCBY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
There is a current need for better bone graft substitutes to
regenerate diseased or damaged bone to its original state and
function. Bioactive glass scaffolds, with a suitable interconnected
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potential to aid the regeneration process by giving cells a tempo-
rary template to grow into. Bioactive glasses can form a chemical
bond with bone and dissolve over time, provoking bone cell activ-
ity. Their dissolution products have been found to up-regulate
seven families of genes in osteoblasts [2,3], termed ‘osteostimula
tion’. 45S5 (46.1 mol% SiO2, 24.4 mol% Na2O, 26.9 mol% CaO and
2.6 mol% P2O5) is the original melt-derived bioactive glass compo-
sition [4] and is produced by quenching from a melt and available
commercially in a powder form, e.g. as the product NovaBone
(NovaBone Products LLC, Alachua, FL). However, 45S5 cannot be
sintered into 3D constructs while maintaining its amorphous glass
structure. This is due to the narrow thermal processing window
between its glass transition temperature (Tg) and its crystallisation
onset temperature (TConset) [5]. To enable sintering of mechanically
robust scaffolds, the glass must be reheated to above Tg to enable
the particles to undergo viscous flow and fuse. However, if the sin-
tering window is too narrow, it is difficult to keep the glass amor-
phous. The transformation between amorphous and crystalline
structure affects bioactivity by altering its dissolution profile [6].
New bioactive glass compositions have recently been designed
with an increased sintering window, allowing thermal processing
post melt quenching [7,8]. An optimum sintering window would
allow viscous flow of the particles to form a homogenous surface
without crystallisation or macrostructure distortion occurring.
Literature currently presents a variety of methods for producing
porous bioactive glass scaffolds, with two processes being predom-
inately used: the foam replica (reticulation) method and robocast-
ing or direct ink writing (extrusion 3D printing). The foam replica
method employs a polyurethane foam to act as a sacrificial tem-
plate to form the scaffold. A glass particle slurry coats the foam
template, which is then burnt out using a two-step sintering pro-
cess creating scaffolds with a porous foam architecture [9]. While,
a porous structure is obtained, the main limitation of this process-
ing method is the mechanical properties of the scaffolds produced.
Due to the processing method, the struts, which take the mechan-
ical load, can end up being hollow, reducing overall strength of the
scaffold [10,11]. In contrast, robocasting is a 3D printing technique
that prints glass particles dispersed within a polymeric binder. For
successful printing, particle size and distribution [12] and the rhe-
ological properties of the binder/glass blend are key. The binder
should exhibit shear thinning rheology, be able to take high parti-
cle loadings and burn out below the Tg of the glass. Typically, 3D
grid-like structures are printed, creating uniform rectangular inter-
connected porosity in x, y and z directions [12].
Both processes have been used to produced scaffolds from the
glass composition 13–93 (54.6 mol% SiO2, 22.4 mol% CaO, 6 mol%
Na2O, 1.7 mol% P2O5, 7.9 mol% K2O, 7.7. mol% MgO). Scaffolds pro-
duced by the foam replica method featured porosities of 85% with
interconnects between 100–500 mm, and compressive strengths of
11 ± 2 MPa [13]. In contrast, robocast scaffolds had comparable
interconnects of 500 mm in xy and 100 mm in z, at porosities of
60% and strengths of 136 ± 22 MPa [14]. Although robocasting
can produce scaffolds of much higher mechanical strengths in
compression, compared to open cell foams, the strength is due to
the grid-like morphology of the scaffolds. As yet, foam-like scaf-
folds that mimic the structure of porous bone have not been 3D
printed in glass or ceramic. It is not yet knownwhether the ordered
pore channels, made by 3D printing, are favourable for bone
ingrowth compared to the more cancellous-like pore foam struc-
tures that clinicians are more familiar with.
An alternative method for producing foam scaffolds is through
direct foaming of a glass particle slurry with the aid of a surfactant
(gel cast foaming) [5]. The surfactant stabilises air bubbles in the
slurry and rapid gelation is then required to solidify the slurry so
that bubbles can form the pores of the scaffold. It is hypothesisedthat the advantage of the direct foaming is that the mechanical
properties are enhanced compared to foam replicates as the struts
will not be hollow. The adapted gel cast foaming process developed
herein evolved from work by Wu et al. [5]. Wu et al.’s process used
in situ polymerisation of acrylic monomers to form the gel. After a
stable foam was formed, the polymer was burned out and the par-
ticles sintered together. The scaffolds produced from ICIE16
(49.46 mol% SiO2, 36.6 mol% CaO, 6.6 mol% Na2O, 1.07 mol% P2O5,
6.6 mol% K2O) glass had porosities of 79%, with modal pore diam-
eters of 379 mm and compressive strength of 1.9 MPa. These values
were a factor of 10 lower than those reported by Fu et al. [13] of
foam replica scaffolds manufactured from 13–93.
The limitation of the Wu et al. process was that the gelation
reaction was so rapid that the window to transfer the foam into
moulds prior to gelation was approximately 2 s. Pouring too early
resulted in a collapse of the foam and too late would not produce
any scaffolds; this made up-scaling difficult. Another problem
was the formation of potassium sodium sulphate on the glass sur-
face during sintering. This was due to the ammonium persulfate
initiator, used for the free radical polymerisation of the acrylic,
reacting with sodium and potassium ions that leached from the
glass particles. Although the sulphate is thought to be non-toxic,
it changed the topography of the surface and hampered sintering
between the particles, reducing compressive strength. A method
that widens the gelation window without potassium sodium sul-
phate formation is needed.
13–93 is the most common bioactive glass used for 3D scaffolds,
due to its thermal processing capability of good viscous flow form-
ing continuous material without crystallisation [8]. However, it
may have lower bioactivity than 45S5 Bioglass due to the higher
silica content forming a highly connected network that is more
resistant to dissolution. Hill and Brauer [15] proposed a method
of predicting bioactivity of bioactive glasses based on their nominal
composition, known as the modified network connectivity (Eq.
(1)). This calculation uses the glass composition (in mol%), where
Mf is the molar fraction of the network forming oxide, e.g. Si, and
M12O and M
IIO are the respective molar fractions of the mono and
divalent modifier oxides within the glass. This calculation assumes
that phosphate forms its own orthophosphate network, charged
balanced by divalent cations.
NC0 ¼ 4ðMf Þ  2ðM
1
2OþMIIOÞ þ 6ðMP2O5 Þ
Mf
ð1Þ
The original 45S5 Bioglass has an NC’ value of 2.11. As 45S5 has
been used clinically with excellent results, the aim here was to
design glass scaffolds that remain amorphous but have a NC’ value
as close to 2.11 as possible. The relationship of network connectiv-
ity and bioactivity is limited by various factors: for example, it
assumes that the glass is homogeneous with a uniform distribution
of ions throughout the system. It also assumes that once a bridging
oxygen bond is broken and replaced with a non-bridging oxygen
that the initial bond disappears, whereas in reality it depends on
the replacing ion and its size and charge. Thirdly it requires the
user to define what role a particular atom will play within the net-
work, which can be a challenge. For example, magnesium’s role
within the glass network is currently debated within the literature.
Watts et al. [16] showed that in their particular compositional ser-
ies magnesium can enter the network as both a former (MgO4) and
a modifier (Mg2+), with 14% of the total magnesium acting as a
network former [16].
Here, the aim was to develop a modified thermal gelation
method for the gel-cast foaming process, combined with glasses
of network connectivity similar to Bioglass, without forming sur-
face crystals as a by-product of the gelation. Three silicate glass
compositions ICIE16, PSrBG, and 13–93 were compared with vary-
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work connectivity values suggest that ICIE16 should be the most
bioactive as its network connectivity is closest to that of 45S5
(2.11), followed by PSrBG and 13–93. A second objective was to
investigate biological response to the new scaffolds in vitro and
in vivo in a critical size rabbit lateral femoral condyle model.2. Materials and methods
2.1. Glass synthesis
All reagents were purchased from Sigma Aldrich UK at >96%
purity, unless otherwise stated. Three glasses ICIE16, PSrBG and
13–93 (Table 1) were produced using high purity silica (SiO2)
(Prince minerals, Stoke-on-Trent), phosphorous pentoxide (P2O5),
magnesium oxides (MgO) and the carbonate equivalent of the
modifying oxides. They were mixed prior to melting for at least
8 h (Wheaton mini roller, UK), then melted at 1400 C for 1.5 h,
in a Pt-5%Au crucible. The melt was then quenched into deionised
water, the frit was collected and dried at 100 C. Frit was then ball
milled at 500 rpm for 6 min (Fritsch Premium Line 7 ball mill) and
sieved (Russell Finex compact sieve shaker with ultrasonic deblin-
der) to yield particles with diameters less than 32 mm.
The glass composition was checked using X-ray Fluorescence
(XRF) and by Inductive coupled plasma optical emission spec-
troscopy (ICP-OES) analysis (Thermo iCAP, Thermo scientific) fol-
lowing lithium metaborate acid digestion. X-ray fluorescence
(XRF) was completed both air and helium using a PANalytical
Epsilon3XLE at 30 kV and 0.250 mA on powders after they were ball
milled and sieved to less than 32 mm. For acid digestion, 100 mg of
glass and 400 mg lithium metaborate were mixed and added to a
Pt-5%Au crucible, the mixture was then heated to 1200 C for
30 min. The glass was then dissolved under sonication in a known
volume of 2 mol nitric acid (Analytical grade, Fisher UK, CAS 7697-
37-2) and then analysed via ICP-OES. Compositional error was less
than 1 mol% for each element.
2.2. Particle size analysis
Particle size was measured using a Malvern Mastersizer 2000
(Malvern Instruments Ltd. UK). To form stable suspensions suitable
for measurement, glass powders were dispersed in water using a
sonicator, and ethylene glycol was added to aid dispersion.
Refractive index values used were glass: 1.54, water: 1.33, ethylene
glycol: 1.44.
2.3. Gel cast foaming of scaffolds
Different ratios of type A porcine gelatin (CAS 9000-70-8) were
dissolved into 20 ml of deionised water at 25 C. Glass powder was
then added with Triton X100 surfactant. The solution was foamed
for 2 min (Kenwood hand mixer), then placed in an ice bath for
8 min until solidified. Samples were then placed in a 20 C freezer
for 20 min followed by 2 h in a 80 C freezer. On removal fromTable 1
Compositional summary of the glasses (mol%) used and their relative network connectivit
Oxide: mol% SiO2 CaO Na2O P2O5 K2O MgO S
45S5 46.13 26.91 24.35 2.6
ICIE16 49.46 36.6 6.6 1.07 6.6
13–93 54.6 22.4 6 1.7 7.9 7.7
PSrBG 44.5 17.8 4 4.5 4 7.5 1the freezer, the scaffolds were freeze dried (CoolSafe 100-4
freeze-drier fitted to a Vacuubrand RZ6 vacuum pump operating
at 110 C with an ultimate total vacuum of 1  102 mbar) for
2 days until dry. Prior to sintering, scaffolds were cut with a scalpel
blade to shape. Samples were then sintered in a two stage process,
with both the temperature and time used being dependent upon
glass composition, all sintering processes were conducted at a
heating rate of 3 C /minute. The values for each variable were
investigated and reported within the results section.
2.4. Samples for in vitro and in vivo studies
Scaffolds of ICIE16 (in vitro and in vivo) and PSrBG (in vivo only)
were produced using the previously stated methodology. The sur-
factant concentration and thermal processing regimes were
selected to obtain similar interconnect pore diameters. ICIE16 scaf-
folds were made using 0.3 ml of surfactant addition, and sintered
using a two-step profile, with dwells at 500 C for 1 h and at
690 C for 1.5 h. PSrBG scaffolds were formed using 0.4 ml of sur-
factant and sintered again using a two-step profile, with dwells
at 500 C for 1 h and at 700 C for 5 h. Both ICIE16 and PSrBG sin-
tered profiles were conducted at a rate of 3 C/min. Scaffolds used
for the in vivo study are summarised in Table 2.
2.5. Nitrogen sorption (BET)
Samples were degassed for 24 h at 200C, nitrogen sorption run
on a Quantachrome (Hook, UK) ASiQWininstrument, with surface
area calculated using the multipoint BET method [17].
2.6. Differential scanning calorimetry
A 50 mg sample of Type A porcine gelatin was placed in a plat-
inum crucible. Analysis was completed in continuously flowing air
up to 1200 C at a heating rate of 10 C min1 using a NETZSCH STA
449C Dual Thermogravimetric Analysis-Differential Scanning
Calorimeter. The reference sample used was alumina. Calibration
scans were run of both empty crucibles and just the reference sam-
ple to reduce error.
2.7. Mercury porosimetry
Mercury Porosimetry was carried out using a Quantachrome
Poremaster 33 (Quantachrome UK, Hook, UK). Sample volumes
were recorded and their masses inputted into the software, cylin-
ders of approximately 1 cm3 were used and five repeats were done
of each sample set tested. The samples were left under vacuum for
30 min prior to infiltration, and then filled with mercury under
nitrogen gas as a function of pressure. Raw data was analysed
using PoreMaster for windows 8.1 software.
2.8. Compression testing
Cube shaped scaffolds with parallel faces and dimensions of
6  6  6 mm were tested under compression using a 10 kN loady in reference to 45S5 (assuming magnesium has the role of network modifier only).
rO Network
formers
Network
modifiers
Possible network
intermediates
Modified network
connectivity
48.73 51.26 2.11
50.53 49.47 2.13
56.30 43.70 7.70 2.58
7.8 49.0 51.0 7.50 2.31
Table 2
Summary of in vivo samples.
Glass Porosity/% Modal interconnect diameter/mm Diameter/mm Thickness/mm Surface Area/m2 g1
PSrBG 88.82 ± 1.83 109.2 ± 4.5 6.54 ± 0.09 1.53 ± 0.06 2.59 ± 0.89
ICIE16 85.76 ± 2.96 111.3 ± 12.2 6.44 ± 0.20 1.49 ± 0.09 5.60 ± 0.69
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fitted. A total of 10 scaffolds of each glass composition were tested
with comparable porosities between 73–77%, the results shown
are the average values and the error bars represent the standard
deviations.2.9. Simulated body fluid testing
Scaffolds of each glass composition, with modal interconnect
sizes between 100–150 mm, were produced and immersed in Sim-
ulated Body Fluid (SBF) [18] using approved conditions, i.e. at a
ratio of 150 mg to 100 ml of solution [19] with the samples sealed
and placed in an orbital incubator (Newbrunswick Scientific – Clas-
sic Series C24) at 120 rpm at 37 C. At each time point (1, 2, 4, 8, 24,
48, 72, 168, 336, 504 and 672 h; n = 3), the pH was measured, a
1 ml sample of SBF taken and subsequently replaced (with stock
SBF solution) to keep the sample/volume ratio constant. At each
time point, scaffolds were rinsed in acetone and dried for further
analysis via SEM, XRD and FTIR. Samples for ICP-OES were diluted
with 9 ml of 2 M nitric acid. They were analysed for each element
present within the glass, if concentration levels were outside of the
0–40 mg ml1 then a further dilution was conducted at a ratio of
1:9 with 2 M nitric acid. The results shown are the averages of each
time point and the error bars represent the standard deviations.2.10. X-ray diffraction (XRD)
Glass scaffolds were ground into a fine powder prior to analysis.
The spectra were collected using a Bruker D2 PHASER desktop X-
ray diffractometer with a step size of 0.0332, 10 s per step, mea-
suring between 5 and 80 degrees 2h. The radiation source was Ni
filtered CuKa.2.11. Fourier transform infrared spectroscopy (FTIR)
All samples were ground into a fine powder prior to testing and
spectra were collected between 450–4000 cm1 at a resolution of
2 cm1 and averaged over 64 scans. The data was collected using
a Scientific Nicolet iS10 Spectrometer operating in attenuated
reflectance (ATR) mode.2.12. Scanning electron microscopy (SEM)
Low magnification images of the scaffolds were collected using
the JEOL JSM 5610 LV with a working distance of 10–12 mm. Sam-
ples were mounted onto conductive stubs using carbon tape and
sputter coated in gold using an Emitech K550 for two minutes at
25 mA. Due to the porous nature of the scaffolds one side was
painted with silver to increase the conductivity of the samples.
Images were taken using a voltage of 5 kV to reduce charging of
the samples. High magnification images were collected using a
Field Emission Gun (FEG) SEM (LEO 5610), samples were sputter
coated in chromium for two minutes at 30 mA. A voltage of 5 kV
was used with a working distance of 5–10 mm.2.13. In vitro cell culture
2.13.1. Dental pulp stem cell isolation
Intact human impacted third molars with immature roots were
collected from healthy patients (3 donors aged 15–20 years) in the
Dental Clinics at the Islamic Azad University of Khorasgan under
approved guidelines by the Ethical committee of Royan institute
(EC/91/1148). All experiments were conducted after patients had
signed informed consent forms. Dental stem cells were isolated
as previously described [20]: the apical papillae of teeth were cut
out with a sterile blade in cold phosphate buffered saline (PBS),
and then extractedmolars were sectioned at cemento-enamel junc-
tion (CEJ) to remove pulp tissue; isolated pulp was washed three
times with PBS, minced and digested in a solution of 4 mg ml1
collagenase type I (Gibco,UK) for approximately 60 min at 37 C.
Single-cell suspensions were prepared by passing the cells through
a 70 lm strainer and were initially grown in Minimum Essential
Medium a-Modification (a-MEM, Sigma, UK) supplemented with
15% fetal bovine serum (FBS, Gibco,UK), 1% L-glutamine (Gibco,
UK), 100 U ml1 penicillin and 100 mg ml1 streptomycin at
37 C, 5% CO2 and were allowed to reach 85% confluency. The
explanted dental pulp stem cells (DPSCs) were then subcultured
in Dulbecco’s Modified Eagle’s medium (DMEM) supplemented
with 10% FBS, 1% L-glutamine (Gibco, UK), 100 U ml1 penicillin
and 100 mg ml1 streptomycin, referred to from further on as com-
plete medium. All experiments were carried out by using DPSCs
from the same donor at passage 3.2.13.2. Cell culture on scaffolds
The ICIE16 scaffolds were cut into 3  3  3 mm cubes and ster-
ilized in dry heat (200 C for 2 h) prior to use. Preconditioning of
scaffolds was performed by immersion in serum-free DMEM
(3 mg glass per ml DMEM), supplemented with 100 U ml1 peni-
cillin and 100 mg ml1 streptomycin, at 37 C for 48 h. Following
preconditioning, the culture media were collected and filtered
through 0.2 lm syringe filters to be analysed by ICP-OES. Following
preconditioning, scaffolds were washed with PBS and transferred
to a 24-well plate. Cell seeding was performed by addition of con-
centrated cell suspension in a drop-wise manner to ensure cell
loading directly onto the scaffolds. Specifically, 100 ll of complete
medium containing 50,000 cells was pipetted directly onto the
scaffolds surface and incubated at 37 C, 5% CO2 for 20 min. The
wells were then filled with 1 ml complete media and cultured for
1, 3, 5 and 7 days, under static conditions at 37 C, 5% CO2, humid-
ified atmosphere. Medium was collected after each time point for
ionic concentration analysis using ICP-OES. The preconditioned
scaffolds were also used for analysis by XRD (protocol above).2.13.3. Cell attachment
Following 24 h of cell culture, as described above, cell-scaffold
constructs were fixed using 2.5% glutaraldehyde (Sigma, UK) in
PBS for 40 min at 4 C, washed with PBS, dehydrated through a ser-
ies of increasing concentrations of ethanol (0, 25, 50, 75 and 100%)
and dried using hexamethyldisilazane (HMDS, Sigma) after which
they were sputter coated with gold and viewed using a SEM
(SEM, Philips XL30) using an accelerating voltage of 5 kV.
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DPSC metabolic activity over time following culture on scaffolds
was assessed using MTS and Alamar blue. Since both assays are
colorimetric, phenol red free DMEM was used. CellTiter 96 Aqu-
eous One Solution Cell Proliferation Assay (Promega, UK) was used
following the manufacturer’s instructions. At each time point,
250 ll of MTS solution was added to each 24-well plate and incu-
bated for 3 h at 37 C. Following incubation, 100 ll were trans-
ferred to a 96-well plate and the absorbance was measured at
450 nm using a microplate reader. Alamar Blue (Invitrogen, UK)
was also used to measure cell metabolic activity. In this assay flu-
orescence intensity is proportional to the number of living cells
and corresponds to metabolic activity of the cell population. At
each time point, media was removed and 500 ll of Alamar blue
solution (1:10 Alamar blue reagent: culture medium) was added
to each well and incubated for 2 h. Fluorescence was measured
on a fluorescence plate reader at 570 nm. The data are expressed
as the mean values and standard deviation (SD) of two individual
experiments each performed in triplicate. Differences between
groups were determined by an Independent T-test with values of
p < 0.05 considered significant.2.14. Statistical analysis
All characterisation in vitro experiments were carried out in
triplicate, from these the averages and standard deviations were
calculated. Within this work the mean values are shown and the
standard deviations are presented as error bars.Fig. 1. SEM images of PSrBG scaffolds foamed with 0.2 ml surfactant and (a) 1 g
gelatin; (b) 2 g of gelatin, sintered at 690 C for 3 h.2.15. In vivo study
All animal procedures were approved and conducted in accor-
dance with institutional (University of Ulster) animal care commit-
tee and National (UK Home Office) guidelines. A total of 4 female
New Zealand half-lop rabbits (2.1–2.8 kg) were used in this study.
General anaesthesia was induced by subcutaneous injection of
ketaset and xylapam (in sterile saline), with palliative pain relief
ensured by subcutaneous injection of Metacam. Rabbits were intu-
bated and an appropriately plane of anaesthesia was maintained
by inhalation of a Fluothane/air mixture.
The surgical site was initially prepared by mechanical clipping
of fur, application of a depilatory cream and 3 successive washes
with chlorhexidine followed by isopropanol. The rabbits were then
placed on their sides and a 5 cm incision over the lateral aspect of
the knee joint was made with a scalpel. The muscle tissue was
blunt dissected, retracted from the underlying bone and connective
tissue overlying the lateral aspect of the femoral condyle was
cleared. A critical-sized 6.5 mm circular defect was drilled in the
femoral condyle down to the level of the marrow cavity (with lib-
eral application of sterile saline to prevent heat-induced osteo-
necrosis) and bleeding minimised by application of pressure. The
pre-sterilized ICIE16 (3 implants) or PSrBG scaffolds (3 implants)
were then press fitted into the lesion until they were level with
the edge of the remaining bony tissue. Muscle tissue was closed
with 6:0 suture (Ethilon) and the skin was closed with 4:0 suture.
After successful implantation on one leg, the procedure was per-
formed on the contra-lateral leg. Two sites in separate rabbits con-
tained no implant (defect-only) and served as controls.
After surgery, animals received prophylactic topical antibiotics
on the surgical site as well as 5 days of oral antibiotics. Pain relief
was also administered for 3 days’ post-surgery in the form of oral
Metacam. At either 7 (one rabbit) or 12 weeks post-implantation
(2 rabbits), animals were euthanised and the femur/scaffold sam-
ples were removed for subsequent X-ray micro tomography
(lCT) examination.The femurs head (scaffolds were included) were scanned using
a laboratory based mCT system (nano-focus, Phoenix|X-ray General
Electric Company, Measurement and Control). The energy of the
scanner used was 70 kV with 140 mA current. Each scan yielded
projection data set of 1000 2D projections, the size of the recon-
structed images was 1989  1989  1000 voxels with an isotropic
voxel size of 9.5 lm. The 3D images of the femur/scaffold sample
were obtained using Avizo Image processing software (Visualisa-
tion Sciences Group, Merignac Cedex, France). Three dimensional
morphology analysis was performed on newly formed bone in
manually selected volume of interest (VOI); the total amount of
newly formed bone was quantified as previously detailed [21].
3. Results and discussion
3.1. Adapted gel-casting process optimisation
The initial aim was to determine whether foam scaffolds could
be produced from low silica glasses using gelatin as the gelation
agent in the gel-cast foaming process. One glass composition
(PSrBG) was used as proof of principle by studying the gelatin to
water ratio and the glass loading. Then, the amount of surfactant
required to form scaffold morphologies suitable for bone ingrowth
[22] and the sintering temperature were then optimised specifi-
cally for each glass composition.
3.1.1. Gelatin concentration for gelation
Gelatin is a natural polymer with viscosity dependent upon the
ambient temperature under certain conditions it can act as a
binder for particles to form mechanically stable green bodies
454 A. Nommeots-Nomm et al. / Acta Biomaterialia 57 (2017) 449–461[23–25]. The effect of gelatin concentration on the ability to pro-
duce a foamed structure, of PSrBG, was investigated using 0.2 ml
of surfactant and scaffolds were sintered for 3 h at 690 C.
Gelatin content was studied at 0.5 g, 1 g and 2 g dissolved in
20 ml of deionised water with 0.2 ml of surfactant addition. At
0.5 g, the gelatin concentration was insufficient to gel the slurry,
resulting in collapse of the foam once agitation was stopped. 1 g
of gelatin produced a successful foam (foam volume of 100 ml
from 40 ml starting slurry) with open pores (Fig. 1a). However,
when the amount of gelatin was increased to 2 g, the viscosity
was too high, and a reduction of foam volume to 60–70 ml was
seen (Fig. 1b) and the pore network became heterogeneous with
pores partially collapsed in some areas. Consequently 1 g of gela-
tin in 20 ml of deionised water was used in subsequent
experiments.3.1.2. Glass concentration in the slurry
During sintering, the polymeric binder, in this case gelatin, was
burnt away leaving the particles supporting one another in the
green body. Once the temperature was raised above Tg, the previ-
ously discrete particles fused through viscous flow, forming contin-
uous surfaces. If the glass loading was sufficient, the foam structure
was maintained, forming scaffolds which resemble the green
body’s original morphology. If there was insufficient packing of
the particles within the green body, slumping of the structure
occurred when the gelatin was burned away, or the foam collapsed
under its weight. The effect of glass loading was investigated for
loads of between 10–30 g of glass in 20 ml of water using 0.2 ml
of Triton X-100. A loading of 25 g of glass was found to be optimal.Fig. 2. (a) SEM images of the effect of surfactant volume on ICIE16, 13–93 and PSrBG g
1:20:25; Scale bar corresponds to 200 lm. (b) interconnect diameter distributions from m
variation in compressive strength with surfactant concentration of scaffolds manufacture3.1.3. Surfactant concentration for the foaming of the slurry
For all glass compositions, the amount of Triton X-100 surfac-
tant added varied between 0.2–0.6 ml at a set glass: gelatin: water
ratio of 25:1:20. Fig. 2a shows SEM images of all three glass com-
positions at surfactant contents of between 0.2–0.6 ml. At low con-
centrations of surfactant (0.2 ml), the scaffolds formed had limited
porosity, with heterogeneous pore morphologies deemed unsuit-
able for bone regeneration. Increasing the concentration of the sur-
factant to 0.3 ml and 0.4 ml improved the homogeneity and
sphericity of the pores. At 0.5 and 0.6 ml surfactant, the pore diam-
eters continued to increase and started to become irregular in
shape. Fig. 2b shows pore interconnect diameter of ICIE16 mea-
sured via mercury porosimetry. Interestingly, above surfactant
concentrations of 0.2 ml, the diameter of the interconnects formed
between pores remained at 100 mm which is considered to be
suitable for tissue ingrowth [26]. This suggests that the formation
of the interconnects was due to rupture of pores during gelation,
which was dependent upon the gelatin properties during freezing,
not the concentration of surfactant within the system. The
porosimetry results corroborated SEM images, from the SEM and
mercury results it was deemed that 0.3 ml of surfactant produced
them most suitable foams for the ICIE16 composition. Fig. 2c
shows the variation in compressive strength of the ICIE16 scaffolds
with their corresponding porosities. As expected, the increase in
surfactant concentration increased the porosity of the scaffolds
resulting in reduced compressive strengths [26]. For both 13–93
and PSrBG compositions, the surfactant concentration had to be
increased to 0.4 ml in order to produce foam volumes of  120 ml
that produced scaffolds with similar pore structures and intercon-
nect sizes to those of the ICIE16 composition.lasses, when gelatin, water and glass concentration within the slurry were kept at
ercury porosimetry of ICIE16 scaffolds made with 0.2, 0.3 and 0.6 ml surfactant; (c)
d from ICIE16 with reference to scaffold porosity. Scaffolds were sintered at 680 C.
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The gel casting method allows scaffolds to be cast and cut into
any required shape. If the sintering profile and particle loading are
optimised, the scaffolds have the same morphology pre and post
sinter. However, if during sintering the viscous flow was too great
it produced distortion within the scaffolds, reducing the pore and
interconnect size. The aim was to achieve mechanically robust
open pored scaffolds which remained amorphous post sintering.
Thermal Gravitation Analysis (TGA) showed that gelatin burned
out of the scaffolds below 500 C (Fig. 3a). Therefore, a two stage
sintering process was adopted, with a dwell of 1 h at 500 C, for
gelatin removal, and a secondary dwell, which is composition
dependent, to sinter the particles.
ICIE16 sintering optimisation is described by Fig. 3. Initially,
the sintering temperature (second dwell period) was investigated.
Four temperatures (680 C, 690 C, 700 C and 710 C), with 1 h
dwell periods (Fig. 3c–f), were compared via SEM. At 680 C and
690 C, limited viscous flow occurred, with shapes of the particlesFig. 3. Investigating effect of sintering regime on ICIE16 scaffolds produced with glass:
gelatin via DSC; b) XRD patterns corresponding to sintering at 690 C for 1–5 h, inset schem
different sintering temperatures with 1 h dwell: (c) 680 C; (d) 690 C; (e) 700 C; and (
Table 3
Summary of processing protocols for the adapted gel-casting process for ICIE16, 13–93 an
Glass D10/D50/D90/mm Slurry composition vol% Water/Gelatin/Glass/Surf
ICIE16 3.1/12.5/35.0 69.77/0.51/28.41/1.30
13–93 3.3/15.8/39.5 67.68/0.50/30.88/0.95
PSrBG 3.3/10.8/30.5 65.53/0.48/32.76/1.22
*Where D10/D50/D90 is the particle size used, the modal interconnect diameter Dmode,visible, indicating incomplete sintering (Fig. 3c, d). At 700 C and
710 C the glass had flowed to form continuous struts
(Fig. 3e, f), however the pore shapes and interconnects had started
to reduce and change morphology due to the amount of flow
which had occurred. Therefore, dwell time at 690 C (Fig. 3b)
was increased from 1 to 1.5 h, which improved sintering, creating
smooth strut morphologies, keeping the scaffold foamed shape,
while maintaining the glasses amorphous structure. When the
dwell temperature was increased to 2 h, small crystallisation
peaks occurred within the XRD patterns and pits formed on the
surface of the scaffold (Fig. 3e–f). Sintering was continued at
690 C for 5 h to determine the crystalline phase formed and
Na4.24Ca3.8 (Si6O18) and Ca2Si4Ca3(PO4)2 were identified (reference
codes 01-078-1650 and 00-049-1674 respectively). The diffraction
peaks for Na4.24Ca3.8 (Si6O18) are at 32.5, 33 and 41 2h, matched
the peaks seen at 2 h, suggesting that this phase formed first, and
then after an extended time at temperature Ca2Si4Ca3(PO4)2
formed.gelatin: water ratio of 25: 1: 20 and 0.3 ml surfactant a) Thermal decomposition of
atic of the sinter schedules used; (c)–(f) SEM images showing degree of sintering at
f) 710 C.
d PSrBG compositions, and the consequent scaffolds properties.
actant Sintering profile Dmode/mm %P/% rmax/MPa
690 C 1.5 h 107.9 ± 8.6 74.9 ± 1.3 3.4 ± 0.3
700 C 1 h 132.4 ± 9.3 75.4 ± 2.1 15.3 ± 1.8
690 C 5 h 124.8 ± 12.4 76.7 ± 0.9 8.4 ± 0.8
%P defines scaffold porosity.
Fig. 4. Characterisation of gel cast foam scaffolds of the three glass compositions, with the process optimised to produce to give a modal interconnect diameter of 100 lm,
according to mercury porosimetry: a) SEM images of the sieved particles; b) SEM images of the foam scaffolds post sintering; c) XRD of the scaffolds; d) pore interconnect size
distributions from mercury porosimetry.
Fig. 5. Compressive strength of ICIE16, PSrBG and 13–93 with similar porosity (%P).
Inset: typical stress-strain results for scaffolds made of ICIE16.
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fore the optimum profile to gain enough flow to form continuous
struts, while avoiding crystallisation, keeping the amorphous
bioactive structure.
Once the process was optimised for ICIE16, the sintering vari-
ables were optimised for the other compositions. The aim was to
produce scaffolds of each glass composition with interconnect
sizes between 100–125 lm. The composition of the glass did also
affect the gel cast foaming process and the process of optimisation
is summarised in Table 3 and Fig. 4.
Fig. 4 shows SEM images that demonstrate the formation of the
scaffolds featuring open pore networks with complete sintering of
the particles. In order to achieve this, the PSrBG had to be sinteredfor 5 h and 13–93 for 1 h at 700 C, due to both having higher Tg
compared to ICIE16 [5,27]. Fig. 4c shows that ICIE16 and 13–93
scaffolds were amorphous post sintering according to XRD. The
XRD pattern for PSrBG showed a small unidentified peak but low-
ering the sintering temperature or dwell time to avoid this left the
particles unsintered.
Compressive strengths varied between glass compositions
(Fig. 5 and Table 3), even though the percentage porosity was sim-
ilar. 13–93 had the highest compressive strength (15.3 ± 1.8 MPa)
compared to PSrBG (8.4 ± 0.8 MPa) and ICIE16 (3.4 ± 0.3 MPa). Typ-
ical stress-strain results are shown in the inset for ICIE16 in Fig. 5.
The higher strength of 13–93 was expected due to its higher net-
work connectivity, and enhanced thermal processing.
13–93 was used as a bench mark against other scaffolds within
literature. Work by Fu et al. produced scaffolds with similar mor-
phology with porosities of 85 ± 2% and compressive strengths of
11 ± 1 MPa for cylindrical scaffolds of 12 mm length and 6 mm in
diameter [13]. The scaffolds produced by gel cast foaming gave
slightly higher compressive strengths when tested.3.2. Dissolution and apatite layer formation
Scaffolds of the three compositions and equivalent porosity and
similar Dmode values were compared in SBF (Fig. 6). The pH of the
SBF control was stable at around 7.4 throughout the time-period
of the study, whereas the pH of the solution containing the glass
scaffolds increased due to exchange of cations from the glass with
H+ from the SBF. ICIE16 caused the highest pH increase, peaking at
8.1 after 500 h of immersion, due to its lower network connectivity
compared to PSrBG and 13–93, for which pH increased to 7.73 and
7.75 respectively by 500 h. This higher increase in pH was a result
of a greater Ca2+ ion release (287.2 ± 8.1 mg ml1 500 h compared to
204–109 mg ml1 for the other glasses) which exchanged with of
H+ from the SBF.
Fig. 6. Dissolution profiles in SBF following immersion of 13–93, PSrBG and ICIE16
scaffolds.
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regardless of their composition or network connectivity, with a
steep release in the first 7 days followed by plateau at 48 mg ml1
(13–93) and 58 mg ml1 (ICIE16).Phosphorus reduction from SBF is associated with the formation
of a phosphate-rich (likely to be both calcium and phosphate rich)
layer on the glass surface. Phosphorous reduction in SBF was more
rapid for ICIE16, reducing to 0.5 ± 0.2 mg ml1 by 168 h. Phospho-
rous levels in SBF containing PSrBG stayed stable at
31.87 ± 0.4 mg ml1 over the first 24 h. After 24 h, it reduced stea-
dily to 14.2 ± 0.6 mg ml1 by the end of the study, indicating precip-
itation. Phosphorous content of the SBF containing 13–93
increased until 24 h, showing release of phosphate from the glass,
before it reduced to 2.73 ± 1.2 mg ml1 by the end of the study.
Phosphate is likely to have been released from all scaffolds, but
the phosphate content of ICIE16 and 13–93 was lower than PSrBG.
FTIR spectra of ICIE16 after SBF immersion showed a change at
wavenumber 571 and 602 cm1 by 72 h (Fig. 7A), corresponding to
P-O bending vibrations synonymous with orthophosphate forma-
tion, which is a component of HCA. XRD patterns show a change
in the shape of the amorphous halo as immersion time in SBF
increased, with a broad peak developing at 32 2h which corre-
sponds to (211) of HCA, and a secondary peak at 26 2h.
The P-O bending bands in the FTIR spectra of 13–93 scaffolds
were not clearly defined at 571 and 602 cm1 until 1 week of
immersion, compared to 72 h for ICIE16. The XRD results showed
a gradual shape change of the amorphous halo with time, as it
did for ICIE16, but at a slower rate for 13–93.
PSrBG FTIR results did not show the twin bands associated with
the P-O bending at 571 and 602 cm1 but instead presented a
broader band, often associated with amorphous calcium phosphate
[28]. Slower HCA formation is likely to be due to the lower pH rise
in the SBF (Fig. 6). The XRD of PSrBG showed a subtle change over
the length of the study with HA peaks developing at 26, 32, 46
and 49 2h. However, these were masked by a predominant peak
at 31 2h, which formed during sintering.
When comparing the SEM images, by 3 weeks (Fig. 7c) all glass
compositions had a continuous coating upon the surface. 13–93
had similar needle like formation as ICIE16, however their forma-
tion took longer than ICIE16. PSrBG SEM images showed a different
morphology formed upon the surface compared with ICIE16 or 13–
93, suggesting that the more complex composition affects HCA for-
mation, retarding it compared to 13–93, even though the NC’ was
much lower.
From the results, phosphorous reduction (measured by ICP) and
calcium phosphate layer formation (measured by XRD and FTIR)
was much faster in SBF containing ICIE16 than in SBF containing
13–93 or PSrBG. This could be for two reasons: there was much
more calcium available from ICIE160s composition for dissolution
and therefore for a calcium phosphorous rich precipitate to form;
its network connectivity is also closest to that of 45S5, suggesting
that glass dissolution and formation of HCA should be greater than
that of the other two glasses.
XRD of PSrBG indicates the calcium phosphate was not crys-
talline orthophosphate and the morphology shown by SEM sug-
gests that the precipitate is not the same as 13–93 or ICIE16.
This may be due to added strontium being available within the
glass composition. Fredholm et al. [29] suggested that strontium
substitution for calcium within a glass system results in greater
bioactivity due to a weaker network structure as a result of the
lower charge to size ratio of Sr2+ compared to Ca2+. Hoppe et al.
[30] found that strontium substituted 13–93 nanoparticles showed
an inverse relationship between strontium and bioactivity. Theo-
retical ab initio calculations by Zeglinski et al. [31] indicated that
Sr can substitute for Ca in both Ca-1 and 2 sites within the HA lat-
tice, which could support the proposal of a change in morphology
of the precipitate seen at the surface when compared to 13–93 and
ICIE16. 13–93 has the highest network connectivity, suggesting
that it would be the least bioactive however, within this study its
rate of formation of HCA and the relative drop in phosphorus and
Fig. 7. Surface analysis of ICIE16, 13–93 and PSrBG scaffolds after immersion in SBF at 0 and 72 h, 168 h and 3 weeks a) XRD, b) FTIR, c) SEM images at 3 weeks.
Fig. 8. XRD pattern of ICIE16 scaffolds following 48 h preconditioning in DMEM culture medium and SEM micrographs of dental pulp stem cell (DPSC) attachment onto the
surface of the preconditioned scaffolds 24 h after seeding taken at different positions of the scaffold surface. Scale bar corresponds to 10 lm.
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are difficult to compare as both of them have mixed alkali
[32,33] effects contributing to their glass dissolution, as well as dif-
ferent ratios of modifiers: formers: intermediates.
3.3. Cell culture
Following 48 h of preconditioning in DMEM, the scaffolds
retained their amorphous nature with some evidence for HA for-
mation (XRD pattern (Fig. 8) showed a principle peak at 32 2h).
SEM images (Fig. 8) showed DPSC attachment and spreading on
the scaffolds after 24 h of culture. Alamar blue and MTS assays
indicated that cells were metabolically active and hence viable
after 7 days of culture (Fig. 9a, b). The differences in the data
obtained from the two assays can be explained by the fact that
the assays test for intrinsic cell metabolism using different mech-
anisms. Alamar blue assay measures the reduction potential ofthe cells, and the MTS assay evaluates the activity of mitochondrial
enzymes. Fig. 9c presents the ICP results of the media samples col-
lected after each cell culture time-point (in addition to the precon-
ditioning for 48 h). Si was at its highest level (73 ± 0.4 mg ml1) and
remained high after 3 and 5 days in culture. The effect of Si on
osteoprogenitor cells is known to be dose-dependent [34], which
could explain a small drop in cell activity compared to control
for days 1–5. However differentiation was not investigated. At
day 1 and day 3, the calcium level was between 17–22 mg ml1,
being lower than the control (Fig. 9c) suggesting that the calcium
may have been released from the glass initially and then combined
with phosphate in the medium to form an amorphous or thin
calcium phosphate layer on the scaffold surface (as it did in SBF,
Fig. 6). After 5 days of culture, the calcium concentration increased
from 17 ± 4 mg ml1 to 57 ± 17.4 mg ml1, almost twice the concen-
tration of calcium in the control medium (DMEM) (Fig. 9c). The
increase in cytosolic calcium affects a number of cellular functions.
Fig. 9. Cell metabolic activity over time of dental pulp stem cells (DPSC) seeded on
preconditioned (48 h) ICIE16 scaffolds (a) MTS; (b) Alamar blue assay; and (c)
elemental concentration of cell culture media at each time point during cell culture
study. Control was cells cultured on tissue culture plastic (TCP). Day 0 represents
the culture media at the end of 48 h preconditioning of the scaffolds. Results
represent the mean values and standard deviation (SD) of two individual exper-
iments each performed in triplicate. (*) indicates the statistical significant differ-
ence (*p < 0.05 relative to control).
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processes including apoptosis induction and also the function
and activity of mitochondria. Recruitment of Ca2+ from extracellu-
lar environment can enter the mitochondria in various pathways,with unique channels handling transport of calcium to the inner
membrane space resulting in changes in mitochondria activity
[35]. If the intracellular level of calcium increases, hence changing
cellular homeostasis, then this can have an adverse effect on cellu-
lar behaviour. But this phenomenon requires in-depth and thor-
ough investigation.3.4. In vivo study
lCT images from proof of principle in vivo studies (rabbit
femoral condyle model) indicated that ingrowth from the pre-
existing surrounding femoral condyle occurred, resulting in bone
regeneration, following implantation of ICIE16 and PSrBG gel-cast
foam scaffolds at 7 and 12 weeks (Fig. 10). Fig. 10a and b show
the location of the defect site, at time zero, and its relative size
within the lateral femoral condyle. Fig. 10c and d show bone
ingrowth at 7 weeks for PSrBG and Fig. 10e and f show the
ingrowth for ICIE16. As the attenuation of the X-rays by the new
tissue within the defects were similar to that by the host
bone, we can assume the new tissue is new bone, but it will be
confirmed by histology in future work. No cortical bone was evi-
dent at the defect site. The scaffolds were completely degraded.
Fig. 10g and h show the location of the defect site after 10 weeks,
with no scaffold having been implanted. While there was some fill-
ing of the space, there appeared to be little bone growth and corti-
cal bone did not form. At the 7 week time point, both scaffolds
seem to have undergone total dissolution. The lCT imaging indi-
cated that PSrBG stimulated more new bone growth than ICIE16,
with new bone filling 10.3 mm3 of the original defect compared
to 7.1 mm3 for ICIE16. By 12 weeks, the opposite was seen; the
bone growth stimulated by the PSrBG was less than that of ICIE16
(12.0 mm3 compared to 14.4 mm3 for PSrBG and ICIE16 respec-
tively). Cortical bone seemed to be present at the repaired defect
at 12 weeks. The cortical bone around the defect that contained
the ICIE16 was of thicker than it was for PSrBG (Fig. 10i–l). The tra-
beculated structure of the defect was similar to other regions of
porous bone within the femoral head, supporting the hypothesis
that bone remodelling was taking place (Fig. 10). More rapid regen-
eration was seen here compared the pioneering work by Oonishi
et al., who implanted Bioglass particles (particle diameter
<1 mm) in a similar defect, partly due to the Bioglass particles still
remained in the defect at 12 weeks, due to their slower dissolution
[36]. Here, the scaffolds seem to have completely degraded by
7 weeks, and were replaced by bone, which is likely to be because
the scaffold morphology provides the appropriate morphology,
increased surface area (e.g. 5.6 m2 g1 compared to 0.15 m2 g1
for 45S5 particles [37] in a similar particle size range to those used
by Oonishi [36]) and dissolution rate for bone remodelling. Ripa-
monti et al. [38] showed that concave pores could encourage more
rapid osteogenesis and osteoclast remodelling of bioactive glasses
has been observed in vitro [39]. Further experiments are required
to verify this hypothesis, using histology and quantitative meth-
ods. Enhancement of early stage bone repair by PSrBG could be
related to strontium release, which is known to have a positive
effect on the formation and proliferation of osteoblasts, partially
restoring trabecular volume [40]. We also hypothesise that the
lower NC’ of ICIE16, (2.13) enables greater and sustained glass dis-
solution and remodelling over the length of the study as compared
to that of PSrBG (2.31), resulting in enhanced bone formation at
12 weeks. Bone ingrowth and regeneration was much improved
over sol-gel derived scaffolds of similar architecture in rat tibia
defects [32], which is likely to be due to more suitable rate of dis-
solution of cations from the melt-derived scaffolds, compared to
the burst release of calcium ions within the pores of the sol-gel
scaffolds.
Fig. 10. 3D reconstructions and 2D slices of mCT images of bone regeneration in rabbit femoral condyle defects: (a, b) defects without scaffolds at week 0, (a) 3D
reconstruction and (b) 2D slice; (c–f) 2D slices, 7 weeks after implantation of ICIE16 and PSrBG scaffolds; (g,h) 2D slices of defects after 10 weeks that were not implanted
with scaffolds; (i-l) 2D slices, 12 weeks after implantation of ICIE16 and PSrBG scaffolds. 2D slices were all through the centre of the original defect. Sections marked A-A0- D-
D0 highlight the original defect site. Corresponding 3D reconstructions are also shown, in which the blue arrows highlight the original defect site. Reticulated trabecular bone
was observed at 7 weeks followed by growth and development of bone. The morphology of the cortical region restored its pattern at 12 weeks post-operation when bioactive
glass scaffolds were used. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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By utilising the thermal gelation window of gelatin bioactive
glass scaffolds can be produced via the adapted gel-casting
method. Optimising surfactant concentration, while maintaining
a gelatin: water: glass powder ratio of 1: 20:25, and sintering con-
ditions amorphous glass foam structures can be formed with pore
geometries and interconnects suitable for bone ingrowth. This
technique has been adapted for use with three different silicate
glasses, ICIE16, PSrBG and 13–93 all with different chemical com-
positions, and network connectivities. The optimised scaffolds had
75% porosity, and modal interconnect diameters between 100–
150 mm. Scaffolds of ICIE16, PSrBG, and 13–93 had compressive
strengths of which fell within the range of cancellous bone of
3.4 ± 0.3 MPa, 8.4 ± 0.8 MPa and 15.3 ± 1.8 MPa respectively.
An in vivo pilot study comparing gel-cast foams of PSrBG and
ICIE16 indicated that the foamed morphology supports and sus-
tains bone growth across the 12 week time frame within in a
femoral head defect in a rabbit model. Both scaffolds underwent
complete biodegradation and ICIE16 seemed to encouraged more
bone ingrowth than PSrBG after 12 weeks in situ, showing bone
morphology similar to other regions of the femoral head, however
further studies are required develop a deeper understanding of the
potential of these scaffolds to support long-term bone regeneration
in vivo.Acknowledgements
This work was made possible by the facilities and support pro-
vided by the Research Complex at Harwell, funded in part by the
EPSRC (EP/I02249X/1 and EP/I021566/1). Funding was also
received from the EPSRC (EP/I020861/1) and Imperial College
London. Alessandra Pinna is a Marie Sklodowska-Curie Individual
Fellow. Raw data can be obtained from rdm-enquiries@imperial.ac.uk.References
[1] J.R. Jones, Review of bioactive glass: from Hench to hybrids, Acta Biomater. 9
(2013) 4457–4486.[2] I.D. Xynos, A.J. Edgar, L.D.K. Buttery, L.L. Hench, J.M. Polak, Ionic products of
bioactive glass dissolution increase proliferation of human osteoblasts and
induce insulin-like growth factor II mRNA expression and protein synthesis,
Biochem. Biophys. Res. Commun. 276 (2000) 461–465.
[3] A. Hoppe, N.S. Gueldal, A.R. Boccaccini, A review of the biological response to
ionic dissolution products from bioactive glasses and glass-ceramics,
Biomaterials 32 (2011) 2757–2774.
[4] L.L. Hench, The story of Bioglass, J. Mater. Sci. – Mater. Med. 17 (2006) 967–
978.
[5] Z.Y. Wu, R.G. Hill, S. Yue, D. Nightingale, P.D. Lee, J.R. Jones, Melt-derived
bioactive glass scaffolds produced by a gel-cast foaming technique, Acta
Biomater. 7 (2011) 1807–1816.
[6] O.P. Filho, G.P. La Torre, L.L. Hench, Effect of crystallization on apatite-layer
formation of bioactive glass 45S5, J. Biomed. Mater. Res. 30 (1996) 509–514.
[7] I. Elgayar, A.E. Aliev, A.R. Boccaccini, R.G. Hill, Structural analysis of bioactive
glasses, J. Non-Cryst. Solids 351 (2005) 173–183.
[8] M.D. O’Donnell, R.G. Hill, Influence of strontium and the importance of glass
chemistry and structure when designing bioactive glasses for bone
regeneration, Acta Biomater. 6 (2010) 2382–2385.
[9] Q.Z. Chen, A.R. Boccaccini, Poly(D,L-lactic acid) coated 45S5 Bioglass (R)-based
scaffolds: processing and characterization, J. Biomed. Mater. Res., Part A 77A
(2006) 445–457.
[10] A. Hoppe, B. Jokic, D. Janackovic, T. Fey, P. Greil, S. Romeis, J. Schmidt, W.
Peukert, J. Lao, E. Jallot, A.R. Boccaccini, Cobalt-releasing 1393 bioactive glass-
derived scaffolds for bone tissue engineering applications, Am. Ceram. Soc.
Appl. Mater. Interfaces 6 (2014) 2865–2877.
[11] F. Baino, M. Ferraris, O. Bretcanu, E. Verne, C. Vitale-Brovarone, Optimization of
composition, structure and mechanical strength of bioactive 3-D glass-ceramic
scaffolds for bone substitution, J. Biomater. Appl. 27 (2013) 872–890.
[12] Q. Fu, E. Saiz, A.P. Tomsia, Bioinspired strong and highly porous glass scaffolds,
Adv. Funct. Mater. 21 (2011) 1058–1063.
[13] Q. Fu, M.N. Rahaman, B.S. Bal, R.F. Brown, D.E. Day, Mechanical and in vitro
performance of 13–93 bioactive glass scaffolds prepared by a polymer foam
replication technique, Acta Biomater. 4 (2008) 1854–1864.
[14] Q. Fu, E. Saiz, A.P. Tomsia, Direct ink writing of highly porous and strong glass
scaffolds for load-bearing bone defects repair and regeneration, Acta Biomater.
7 (2011) 3547–3554.
[15] R.G. Hill, D.S. Brauer, Predicting the bioactivity of glasses using the network
connectivity or split network models, J. Non-Cryst. Solids 357 (2011) 3884–
3887.
[16] S.J. Watts, R.G. Hill, M.D. O’Donnell, R.V. Law, Influence of magnesia on the
structure and properties of bioactive glasses, J. Non-Cryst. Solids 356 (2010)
517–524.
[17] S. Brunauer, L.S. Deming, W.E. Deming, E. Teller, On a theory of the van der
Waals adsorption of gases, J. Am. Chem. Soc. 62 (1940) 1723–1732.
[18] T. Kokubo, S. Ito, Z.T. Huang, T. Hayashi, S. Sakka, T. Kitsugi, T. Yamamuro, Ca,
P-rich layer formed on high-strength bioactive glass-Ceramic A-W, J. Biomed.
Mater. Res. 24 (1990) 331–343.
[19] A.L.B. Macon, T.B. Kim, E.M. Valliant, K. Goetschius, R.K. Brow, D.E. Day, A.
Hoppe, A.R. Boccaccini, I.Y. Kim, C. Ohtsuki, T. Kokubo, A. Osaka, M. Vallet-Regi,
D. Arcos, L. Fraile, A.J. Salinas, A.V. Teixeira, Y. Vueva, R.M. Almeida, M. Miola, C.
A. Nommeots-Nomm et al. / Acta Biomaterialia 57 (2017) 449–461 461Vitale-Brovarone, E. Verne, W. Hoeland, J.R. Jones, A unified in vitro evaluation
for apatite-forming ability of bioactive glasses and their variants, J. Mater. Sci.
– Mater. Med. 26 (2015) 115.
[20] S. Gronthos, J. Brahim, W. Li, L.W. Fisher, N. Cherman, A. Boyde, P. DenBesten,
P.G. Robey, S. Shi, Stem cell properties of human dental pulp stem cells, J. Dent.
Res. 81 (2002) 531–535.
[21] H. Geng, N.M. Todd, A. Devlin-Mullin, G. Poologasundarampillai, T.B. Kim, K.
Madi, S. Cartmell, C.A. Mitchell, J.R. Jones, P.D. Lee, A correlative imaging based
methodology for accurate quantitative assessment of bone formation in
additive manufactured implants, J. Mater. Sci. – Mater. Med. 27 (2016) 9.
[22] J.R. Jones, L.L. Hench, Regeneration of trabecular bone using porous ceramics,
Curr. Opin. Solid State Mater. Sci. 7 (2003) 301–307.
[23] L.J. Vandeperre, A.M. De Wilde, J. Luyten, Gelatin gelcasting of ceramic
components, J. Mater. Process. Technol. 135 (2003) 312–316.
[24] G. Novajra, P. Perdika, R. Pisano, M. Miola, A. Bari, J.R. Jones, R. Detsch, A.R.
Boccaccini, C. Vitale-Brovarone, Structure optimisation and biological
evaluation of bone scaffolds prepared by co-sintering of silicate and
phosphate glasses, Adv. Appl. Ceram. 114 (2015) S48–S55.
[25] G. Novajra, P. Perdika, R. Pisano, F. Baino, J.R. Jones, A.R. Boccaccini, R. Detsch,
C. Vitale-Brovarone, Tailoring of bone scaffold properties using silicate/
phosphate glass mixtures, Key Eng. Mater. 631 (2015) 283–288.
[26] S.F. Hulbert, S.J. Morrison, J.J. Klawitter, Tissue reaction to three ceramics of
porous and non-porous structures, J. Biomed. Mater. Res. 6 (1972) 347–374.
[27] S. Fagerlund, J. Massera, M. Hupa, L. Hupa, T-T–T behaviour of bioactive glasses
1–98 and 13–93, J. Eur. Ceram. Soc. 32 (2012) 2731–2738.
[28] M.R. Filgueiras, G. La Torre, L.L. Hench, Solution effects on the surface reactions
of a bioactive glass, J. Biomed. Mater. Res. 27 (1993) 445–453.
[29] Y.C. Fredholm, N. Karpukhina, R.V. Law, R.G. Hill, Strontium containing
bioactive glasses: glass structure and physical properties, J. Non-Cryst. Solids
356 (2010) 2546–2551.
[30] A. Hoppe, B. Sarker, R. Detsch, N. Hild, D. Mohn, W.J. Stark, A.R. Boccaccini, In
vitro reactivity of Sr-containing bioactive glass (type 1393) nanoparticles, J.
Non-Cryst. Solids 387 (2014) 41–46.
[31] J. Zeglinski, M. Nolan, M. Bredol, A. Schatte, S.A.M. Tofail, Unravelling the
specific site preference in doping of calcium hydroxyapatite with strontiumfrom ab initio investigations and Rietveld analyses, Phys. Chem. Chem. Phys.
14 (2012) 3435–3443.
[32] D. Groh, F. Dohler, D.S. Brauer, Bioactive glasses with improved processing.
Part 1. Thermal properties, ion release and apatite formation, Acta Biomater.
10 (2014) 4465–4473.
[33] M. Tylkowski, D.S. Brauer, Mixed alkali effects in Bioglass 45S5, J. Non-Cryst.
Solids 376 (2013) 175–181.
[34] O. Tsigkou, J.R. Jones, J.M. Polak, M.M. Stevens, Differentiation of fetal
osteoblasts and formation of mineralized bone nodules by 45S5 Bioglass (R)
conditioned medium in the absence of osteogenic supplements, Biomaterials
30 (2009) 3542–3550.
[35] S. Patergnani, J.M. Suski, C. Agnoletto, A. Bononi, M. Bonora, E. De Marchi, C.
Giorgi, S. Marchi, S. Missiroli, F. Poletti, A. Rimessi, J. Duszynski, M.R.
Wieckowski, P. Pinton, Calcium signaling around mitochondria associated
membranes (MAMs), Cell Commun. Signal 9 (2011) 10.
[36] H. Oonishi, L.L. Hench, J. Wilson, F. Sugihara, E. Tsuji, M. Matsuura, S. Kin, T.
Yamamoto, S. Mizokawa, Quantitative comparison of bone growth behavior in
granules of Bioglass (R), A-W glass-ceramic, and hydroxyapatite, J. Biomed.
Mater. Res. 51 (2000) 37–46.
[37] P. Sepulveda, J.R. Jones, L.L. Hench, Characterization of melt-derived 45S5 and
sol-gel-derived 58S bioactive glasses, J. Biomed. Mater. Res. 58 (2001) 734–
740.
[38] U. Ripamonti, S. Ma, A.H. Reddi, The critical role of geometry of porous
hydroxyapatite delivery system in induction of bone by osteogenin, a bone
morphogenetic protein, Matrix 12 (1992) 202–212.
[39] S. Midha, W. van den Bergh, T.B. Kim, P.D. Lee, J.R. Jones, C.A. Mitchell,
Bioactive glass foam scaffolds are remodelled by osteoclasts and support the
formation of mineralized matrix and vascular networks in vitro, Adv.
Healthcare Mater. 2 (2013) 490–499.
[40] P.J. Marie, M. Hott, D. Modrowski, C. De Pollak, J. Guillemain, P. Deloffre, Y.
Tsouderos, An uncoupling agent containing strontium prevents bone loss by
depressing bone resorption and maintaining bone formation in estrogen-
deficient rats, J. Bone Miner. Res. 20 (2005) 1065–1074.
